Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1989-12-29
1993-07-06
Wax, Robert A.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
530384, 530350, 435 696, 435 697, 435219, C07K 1512, C12N 964
Patent
active
052255379
ABSTRACT:
Methods are disclosed for producing hybrid phospholipid-binding proteins from eukaryotic cells. DNA constructs comprising a transcriptional promoter, at least one signal sequence and a hybrid phospholipid-binding protein coding sequence comprising at least one lipocortin lipid-binding domain joined to a gla-domainless, vitamin K-dependent protein and a transcriptional terminator are also disclosed.
REFERENCES:
patent: 4770999 (1988-09-01), Kaufman et al.
patent: 4775624 (1988-10-01), Bang et al.
patent: 4784950 (1988-11-01), Hagen et al.
Furic et al. 1988. Cell 53:505-518.
Nagai et al. 1987, Methods in Enzymology 153:461-481.
Haagsman et al. 1987, J. Biol. Chem. 262(2):13877-13880.
Pan and Price, "The propeptide of rat bone .gamma.-carboxyglutamic acid protein shares homology with other vitamin K-dependent protein precursors", Proc. Natl. Acad. Sci. USA 82:6109-6113, 1985.
Marlar et al., "Mechanism of Action of Human Activated Protein C, a Thrombin-Dependent Anticoagulant Enzyme", Blood 59:1067-1072, 1982.
Kisiel, et al., "Proteolytic Activation of Protein C from Bovine Plasma", Biochemistry 15:4893-4900, 1976.
Sugo et al., "Protein C in Bovine Plasma after Warfarin Treatment", J. Biol. Chem. 260:10453-10457, 1985.
Rannels et al., "Vitamin K-dependent carboxylation of pulmonary surfactant-associated proteins", Proc. Natl. Acad. Sci. USA 84:5952-5956, 1987.
Ross et al., "Phospholipid Binding and Biophysical Activity of Pulmonary Surfactant-associated Protein (SAP)-35 and Its Non-collagenous COOH-terminal Domains", J. Biol. Chem. 261:14283-14291 (1986).
Busby et al., "Expression of active human factor IX in transfected cells," Nature 316:271-273, 1985.
Kaufman et al., "Expression, Purification, and Characterization of Recombinant .gamma.-Carboxylated Factor IX Synthesized in Chinese Hamster Ovary," J. Biol. Chem. 261:9622-9628, 1986.
de la Salle et al., "Active .gamma.-carboxylated human factor IX expressed using recombinant DNA techniques," Nature 316:268-270, 1985.
Jorgensen et al., "Expression of Completely .gamma.-Carboxylated Recombinant Human Prothrombin," J. Biol. Chem. 262:6729-6734, 1987.
Jackson, "Calcium Ion Binding to .gamma.-Carboxyglutamic Acid-Containing Proteins From the Blood Clotting System: What We Still Don't Understand," in Current Advances in Vitamin K Research: A Steenbock Symposium, Suttie (ed,), New York, N.Y., pp. 305-324, 1988.
Fung and MacGillivray, "Organization of the Genes Coding for the Vitamin K-Dependent Clotting Factors," in Current Advances in Vitamin K Research: A Steenbock Symposium, Suttie (ed.), New York, N.Y., pp. 143-151, 1988.
Price et al., "Molecular cloning of matrix Gla protein: Implications for substrate recognition by the vitamin K-dependent .gamma.-carboyxlase," Proc. Natl. Acad. Sci. USA 84:8335-8339, 1987.
Tait et al., "Placental Anticoagulant Proteins: Isolation and Comparative Characterization of Four Members of the Lipocortin Family," Biochemistry 27:6268-6276, 1988.
Funakoshi et al., "Primary Structure of Human Placental Anticoagulant Protein," Biochemsitry 26:8087-8092, 1987.
Glenney, Jr. et al., "Calpactins: Two Distinct Ca.sup.++ -regulated Phospholipid- and Actin-binding Proteins Isolated from Lung and Placenta," J. Cell Biol. 104:503-511, 1987.
Kristensen et al., "Primary Structure of Bovine Calpactin I Heavy Chain (p36), a Major Cellular Substrate for Retroviral Protein-Tyrosine Kinases: Homology with the Human Phospholipase A.sub.2 Inhibitor Lipocortin," Biochemistry 25:4497-4503, 1986.
Saris et al., "The cDNA Sequence for the Protein-Tyrosine Kinase Substrate p36 (Calpactin I Heavy Chain) Reveals a Multidomain Protein with Internal Repeats," Cell 46:201-212, 1986.
Schlaepfer et al., "Structural and functional characterization of endonexin II, a calcium- and phospholipid-binding protein," Proc. Natl. Acad. Sci. USA 84:6078-6082, 1987.
Wallner et al., "Cloning and expression of human lipocortin, a phospholipase A.sub.2 inhibitor with potential anti-inflammatory activity," Nature 320:77-81, 1986.
Crompton et al., "Diversity in the Lipocortin/Calpactin Family," Cell 55:1-3, 1988.
Geisow, "Common domain structure of Ca.sup.2+ and lipid-binding proteins," FEBS Lett. 203:99-103, 1986.
Geisow et al., "A consensus amino-acid sequence repeat in Torpedo and mammalian Ca.sup.2+ -dependent membrane-binding proteins," Nature 320:636-638, 1986.
Huang et al., "Two Human 35 kd Inhibitors of Phospholipase A.sub.2 Are Related to Substrates of pp60.sup.v-STC and of the Epidermal Growth Factor Receptor/Kinase," Cell 46:191-199, 1986.
Pepinsky et al., "Purification and Partial Sequence Analysis of a 37-kDa Protein that Inhibits Phospholipase A.sub.2 Activity from Rat Peritoneal Exudates," J. Biol. Chem. 261:4239-4246, 1986.
Pepinsky et al., "Five Distinct Calcium and Phospholipid Binding Proteins Share Homology with Lipocortin I," J. Biol. Chem. 263:10799-10811, 1988.
Kretsinger and Creutz, "Consensus in exocytosis," Nature 320:573, 1986.
Iwasaki et al., "Structure and Expression of cDNA for an Inhibitor of Blood Coagulation Isolated from Human Placenta: A New Lipocortin-Like Protein," J. Biochem. 102:1261-1273, 1987.
Foster and Davie, "Characterization of a cDNA coding for human protein C," Proc. Natl. Acad. Sci. USA 81:4766-4770, 1984.
Foster et al., "The nucleotide sequence of the gene for human protein C," Proc. Natl. Acad. Sci. USA 82:4673-4677, 1985.
Hagen et al., "Characterization of a cDNA coding for human factor VII," Proc. Natl. Acad. Sci. USA 83:2412-2416, 1986.
O'Hara et al., "Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation," Proc. Natl. Acad. Sci. USA 84:5158-5162, 1987.
Kurachi and Davie, "Isolation and characterization of a cDNA coding for human factor IX," Proc. Natl. Acad. Sci. USA 79:6461-6464, 1982.
Anson et al., "The gene structure of human anti-haemophilic factor IX," EMBO J. 3:1053-1060, 1984.
Leytus et al., "Characterization of a cDNA coding for human factor X," Proc. Natl. Acad. Sci. USA 81:3699-3702, 1984.
Leytus et al., "Gene for Human Factor X: A Blood Coagulation Factor Whose Gene Organization Is Essentially Identical with That of Factor IX and Protein C," Biochemistry 25:5098-5102, 1986.
Lundwall et al., "Isolation and sequence of the cDNA for human protein S, a regulator of blood coagulation," Proc. Natl. Acad. Sci. USA 83:6716-6720, 1986.
Hoskins et al., "Cloning and characterization of human liver cDNA encoding a protein S precursor," Proc. Natl. Acad. Sci. USA 84:349-353, 1987.
Degen et al., "Characterization of the Complementary Deoxyribonucleic Acid and Gene Coding for Human Prothrombin," Biochemistry 22:2087-2097, 1983.
Kurachi et al., "Cloning and sequence of cDNA coding for .alpha..sub.1 -antitrypsin," Proc. Natl. Acad. Sci. USA 78:6826-6830, 1981.
Tone et al., "Structure of Human .alpha..sub.2 -Plasmin Inhibitor Deduced from the cDNA Sequence," J. Biochem. (Tokyo) 102:1033-1041, 1987.
Watson, "Compilation of published signal sequences," Nuc. Acids Res. 12:5145-5164, 1984.
Pennica et al., "Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli," Nature 301:214-221, 1983.
von Heijne, "Patterns of Amino Acids near Signal-Sequence Cleavage Sites," Eur. J. Biochem. 133:17-21, 1983.
von Heijne, "How Signal Sequences Maintain Cleavage Specificity," J. Mol. Biol. 173:243-251, 1984.
von Heijne, "A new method for predicting signal sequence cleavage sites," Nuc. Acids Res. 14:4683-4690, 1986.
Furman Keith C.
Wax Robert A.
ZymoGenetics Inc.
LandOfFree
Methods for producing hybrid phospholipid-binding proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for producing hybrid phospholipid-binding proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for producing hybrid phospholipid-binding proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1690841